Aceragen Inc Stock Ownership - Who owns Aceragen?

Insider buying vs selling

Have Aceragen Inc insiders been buying or selling?
Michael R. DoughertyDirector2023-01-1133,523$0.44
John J. KirbyCHIEF FINANCIAL OFFICER2023-01-06119,957$0.71
Bryant David LimSVP AND GENERAL COUNSEL2023-01-06119,957$0.71
Andrew R. JordanCHIEF STRATEGY OFFICER2023-01-0673,940$0.71
Michael R. DoughertyDirector2022-10-0358,516$0.38
Pillar Invest Corp10% Owner2022-09-221,533,159$0.01
Michael R. DoughertyDirector2022-07-0150,086$0.44
Michael R. DoughertyDirector2022-04-0141,155$0.54

1 of 1

ACGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACGN insiders and whales buy or sell their stock.

ACGN Shareholders

What type of owners hold Aceragen Inc stock?
Pillar Invest Corp843.62%30,943,672$92.83MInsider
Pillar Pharmaceuticals I LP371.50%13,626,469$40.88MInsider
Senator Investment Group LP239.23%8,774,905$26.32MInsider
Baker Biotech Capital GP LLC158.11%5,799,598$17.40MInsider
Baker Biotech Capital Ii GP LLC138.90%5,094,924$15.28MInsider
Baker Brothers Life Sciences Capital GP LLC136.69%5,013,762$15.04MInsider
Baker Bros Advisors LP121.23%4,446,590$13.34MInsider
Pillar Pharmaceuticals Iii LP70.88%2,600,000$7.80MInsider
Youssef El Zein43.41%1,592,092$4.78MInsider
John Clayton Taylor40.06%1,469,482$4.41MInsider

1 of 3

ACGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACGN3.53%96.47%Net BuyingNet Selling
NAVB2.62%97.38%Net Buying
ADIL6.07%14.66%Net Buying

Aceragen Stock Ownership FAQ

Who owns Aceragen?

Aceragen (NASDAQ: ACGN) is owned by 88.19% institutional shareholders, 2,410.52% Aceragen insiders, and 0.00% retail investors. Pillar Invest Corp is the largest individual Aceragen shareholder, owning 30.94M shares representing 843.62% of the company. Pillar Invest Corp's Aceragen shares are currently valued at $93.14M.

If you're new to stock investing, here's how to buy Aceragen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.